166 related articles for article (PubMed ID: 18813818)
21. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
22. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
[TBL] [Abstract][Full Text] [Related]
24. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome.
Huang HY; Li CF; Huang WW; Hu TH; Lin CN; Uen YH; Hsiung CY; Lu D
Surgery; 2007 Jun; 141(6):748-56. PubMed ID: 17560251
[TBL] [Abstract][Full Text] [Related]
25. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors.
Menéndez P; Padilla D; Cubo T; Villarejo P; Gambí D; Menéndez JM; Colina F; García M; Lora D; Martín J
Hepatogastroenterology; 2011; 58(105):76-80. PubMed ID: 21510290
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of 63 cases with gastric gastrointestinal stromal tumors].
Rong L; Wan YL; Nian WD; Liu P; Liang JY
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):24-7. PubMed ID: 19145498
[TBL] [Abstract][Full Text] [Related]
27. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.
Sun B; Qie S; Zhang S; Sun T; Zhao X; Gao S; Ni C; Wang X; Liu Y; Zhang L
Hum Pathol; 2008 Mar; 39(3):444-51. PubMed ID: 18261629
[TBL] [Abstract][Full Text] [Related]
28. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
29. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
[TBL] [Abstract][Full Text] [Related]
30. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
[TBL] [Abstract][Full Text] [Related]
32. [Gastro-intestinal stromal tumours (GISTs): prognostic and therapeutic features].
Ferrarese F; Cecere V
G Chir; 2006 May; 27(5):205-8. PubMed ID: 16857107
[TBL] [Abstract][Full Text] [Related]
33. Stromal tumors of the digestive tract. Prognostic value of mitotic index.
Moral Moral G; Gil Piedra F; Velasco Osés A; Seco Gil JL; de la Plaza Galindo M; Santamaría García JL
Rev Esp Enferm Dig; 1998 May; 90(5):335-44. PubMed ID: 9656753
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumors: a 19 year experience.
Rabin I; Chikman B; Lavy R; Sandbank J; Maklakovsky M; Gold-Deutch R; Halpren Z; Wassermann I; Halevy A
Isr Med Assoc J; 2009 Feb; 11(2):98-102. PubMed ID: 19432038
[TBL] [Abstract][Full Text] [Related]
35. Significance of p53 expression in gastrointestinal stromal tumors.
Yalcinkaya U; Yerci O; Koc EU
Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors for malignant evolution of gastrointestinal stromal tumors].
Andrei S; Andrei A; Tonea A; Andronesi D; Becheanu G; Dumbravă M; Pechianu C; Herlea V; Popescu I
Chirurgia (Bucur); 2007; 102(6):641-50. PubMed ID: 18323226
[TBL] [Abstract][Full Text] [Related]
37. [Multivariate analysis of prognosis in gastrointestinal stromal tumor].
Bai YK; Shao YF; Shi SS; Gao YN; Sun YT; Cheng SJ; Liu XY
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):598-601. PubMed ID: 16438868
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior.
Miao R; Liu N; Wang Y; Li L; Yu X; Jiang Y; Li J
Hepatogastroenterology; 2008; 55(88):2012-5. PubMed ID: 19260469
[TBL] [Abstract][Full Text] [Related]
40. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate?
Goh BK; Chow PK; Kesavan S; Yap WM; Wong WK
J Surg Oncol; 2008 Apr; 97(5):388-91. PubMed ID: 18163461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]